Background: Body mass index is an established risk factor for post-menopausal breast
Introduction:
Obesity is a risk factor for many common chronic diseases, including breast cancer in postmenopausal women (1, 2) and type 2 diabetes (T2D). Many epidemiologic studies have also reported diabetics to have a greater risk of breast cancer than non-diabetics, independent of body weight (3, 4) . Biological markers of obesity and diabetes, such as insulin and insulin-like growth factors (IGFs), have been associated with breast cancer risk (5-7), which suggests that there may be shared biological processes in the etiology of these common phenotypes. We further explored the hypothesis of shared etiologic pathways for obesity, T2D and breast cancer, by testing for pleiotropic effects of 31 established risk variants for T2D (n=18) and obesity (n=13) in a study of 1,915 breast cancer cases and 2,884 breast cancer controls from the Multiethnic Cohort (MEC).
Genotyping of the 31 SNPs was performed using the allelic discrimination assay. The genotype completion rate for each SNP was >95.0% for cases and controls (average 99.1%). Hardy-Weinberg Equilibrium (HWE) was assessed for each allele in each racial/ethnic group and of the 155 tests, 7 were significant while 8 were expected.
Statistical analysis:
We tested for log-additive effects of the 31 variants with odds ratios estimated using unconditional logistic regression adjusted for age (quartiles), body mass index (quartiles), self-reported diabetes and race/ethnicity (in pooled analysis). To account for multiple hypothesis testing, an α ≤ 0.0016 (0.05/31 tests) was used. To examine the combined contribution of all variants on breast cancer risk, we constructed summary risk scores, taken as the number of risk alleles for the 18 validated T2D SNPs, for the 13 validated obesity SNPs and for the total of 31 T2D/obesity SNPs, respectively. Individuals missing genotypes were given the mean score for that variant within each population of the same race/ethnicity. We excluded from the analysis 32 (1.7%) cases and 78 (2.7%) controls with missing genotypes for ≥ 10 SNPs. Analysis for overall breast cancer risk was conducted on 1,883 cases and 2,806 controls. We also conducted analyses stratified by ER status (ER+ cases, n=1,217; ER-cases, n=299). The statistical analysis was performed using the SAS 9.2 package, SAS Institute Inc., Cary, North Carolina.
Results:
The mean age of the breast cancer cases (65.3 years at diagnosis) was only slightly higher than that of controls (64.9 years at the time of blood draw).
We observed a nominally significant association (p<0.05) with only 1 variant in the pooled analysis (Table 1 ) whereas 1.6 were expected. The most significant findings included inverse associations with rs5219 (KCNJ11) among all cases, (OR=0.89, P=0.012) and ER-cases (OR=0.73, P=0.0031), as well as with rs864745 (JAZF) in ERcases (OR=0.75, P=0.0020). These associations, however, were no longer significant after adjusting for multiple comparisons (Table 1) . Results were similar when limiting the analysis to postmenopausal women (n=1,197 cases and 1,731 controls).
We also did not find any significant association of the aggregate risk scores comprised of the T2D, obesity or T2D/obesity risk alleles with breast cancer risk (T2D SNPs: OR=1.01, P=0.31; obesity SNPs: OR=1.02, P=0.24; All SNPs: OR=1.01, P=0.14).
Discussion:
We found no strong evidence that the validated risk variants for T2D and obesity are associated with breast cancer risk among women of various ethnicities. Neither did we find any significant association between a summary risk score comprised of the risk alleles for these variants and breast cancer risk. We had adequate statistical power (80%)
to detect an OR of 1.21 for SNPs with a MAF of 0.10, and an OR of 1.15 for SNPs with a MAF of 0.20. However, power may be lower as most of these markers of T2D and obesity risk were identified in GWAS among men and women of European ancestry and may not be strongly correlated with the functional alleles in all populations.
In conclusion, while obesity and, to a lesser extent, T2D are risk factors for breast cancer, we found no evidence that the known risk variants for T2D or obesity are associated with breast cancer risk in a multiethnic population. These data suggest that the potential for a shared biology between T2D/obesity and breast cancer is not due to pleiotropic effects of these risk variants. 
Acknowledgements:
The Population Architecture Using Genomics and Epidemiology (PAGE) 
